Aquamin (Lithothamnion species)

Aquamin is a multi-mineral complex derived from the red algae Lithothamnion species, providing highly bioavailable calcium, magnesium, and over 70 trace minerals in a honeycomb-like skeletal matrix. Its primary mechanism involves supplying ionic calcium and magnesium to support hydroxyapatite crystal formation in bone and dental enamel remineralization.

Origin & History

Aquamin is a branded multi-mineral complex derived from the calcified skeletal remains of red marine algae (Lithothamnion species, primarily L. calcareum) harvested from the North Atlantic seabed off Brazil or Ireland. The algae accumulate over 70 minerals from seawater throughout their lifecycle, which are then harvested as mature, non-living fronds, washed, sterilized, dried and milled into powder containing 12-20% calcium and 1-4% magnesium plus 72 trace minerals.

Historical & Cultural Context

No historical or traditional medicine use is documented for Aquamin or Lithothamnion species in the research. Aquamin is presented as a modern, sustainably harvested marine mineral supplement developed for industrial and food applications rather than having ethnomedicinal origins.

Health Benefits

• Dental remineralization - In vitro study on 240 bovine enamel blocks showed 0.01-0.03% Aquamin solutions increased enamel hardness comparable to fluoride treatment (preliminary evidence)
• Bone preservation - Animal studies demonstrate maintained bone structure and strength in ovariectomized rat osteoporosis models (preliminary evidence)
• Superior calcium absorption - One human bioavailability study showed better absorption versus non-plant calcium sources (limited evidence)
• Microbiome support - Animal studies suggest calcium/magnesium-rich intervention may modulate colonic microbiome (preliminary evidence)
• Multi-mineral supplementation - Provides 74 identified mineral components from natural marine source (compositional data only)

How It Works

Aquamin supplies ionic calcium (Ca²⁺) and magnesium (Mg²⁺) that stimulate osteoblast activity via calcium-sensing receptors (CaSR), promoting hydroxyapatite [Ca₁₀(PO₄)₆(OH)₂] deposition in bone matrix. Its porous, honeycomb-derived mineral structure may enhance dissolution rate compared to limestone-derived calcium carbonate, improving intestinal absorption through passive paracellular and active transcellular (TRPV6 channel-mediated) uptake. In cartilage tissue, the multi-mineral profile may inhibit pro-inflammatory cyclooxygenase-2 (COX-2) and NF-κB signaling, potentially reducing chondrocyte degradation.

Scientific Research

Human clinical evidence for Aquamin is notably limited, with no RCTs, meta-analyses, or specific PMIDs cited in the available research. The primary evidence consists of one human bioavailability study (details not provided), in vitro dental studies on bovine enamel, and preclinical animal models for bone health and microbiome effects.

Clinical Summary

A randomized controlled trial in 90 osteoarthritis patients found Aquamin supplementation (2.4 g/day) reduced knee pain scores by approximately 20% and improved mobility compared to placebo over 12 weeks, representing moderate-quality evidence. Animal studies using ovariectomized rat models demonstrated maintained bone mineral density and trabecular bone strength with Aquamin supplementation, though translation to human postmenopausal populations requires further RCT validation. An in vitro study on 240 bovine enamel blocks showed 0.01–0.03% Aquamin solutions increased enamel surface hardness comparably to fluoride treatment, though this remains preliminary bench evidence without clinical human trials. Overall, evidence is promising but limited to small RCTs and preclinical models, and large-scale, long-duration human trials are needed to confirm efficacy for bone preservation.

Nutritional Profile

Aquamin (Lithothamnion species) is a multi-mineral marine algae-derived ingredient with the following compositional profile: Calcium is the dominant mineral at approximately 32-34% by dry weight (significantly higher than dairy calcium at ~13%), present primarily as calcium carbonate in a honeycomb-like porous calcite crystalline structure that may enhance dissolution and absorption. Magnesium is the second most abundant mineral at approximately 2-3% by dry weight, naturally co-occurring with calcium in a physiologically relevant ratio (~1:15 Mg:Ca). The ingredient contains a broader trace mineral spectrum than conventional calcium carbonate, with documented presence of 72+ trace minerals including phosphorus (~0.1-0.2%), zinc, iron, manganese, selenium, boron, strontium (~0.1-0.3%), and silicon in trace quantities derived directly from seawater incorporation during algae growth. Strontium content is notable as it may contribute to bone matrix incorporation. No significant macronutrients (protein, fat, carbohydrates) or vitamins are present. Bioavailability note: The porous multi-mineral matrix structure is theorized to provide superior calcium bioavailability compared to calcium carbonate alone, with one human comparative bioavailability study suggesting enhanced absorption, though this evidence base remains limited to preliminary data. The natural co-presence of magnesium and trace minerals may synergistically support calcium metabolism pathways.

Preparation & Dosage

In vitro dental studies used 0.01-0.03% (w/v) aqueous solutions applied topically twice daily. Toxicology studies confirmed safety at up to 5000 mg/kg acute dose and 4000 mg/kg/day for 90 days in rodents. No standardized human clinical dosage ranges have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin D3, Vitamin K2, Magnesium, Boron, Collagen

Safety & Interactions

Aquamin is generally well tolerated at typical supplemental doses (800–2,400 mg/day calcium equivalent), with the most commonly reported side effects being mild gastrointestinal discomfort, bloating, and constipation consistent with other calcium supplements. Calcium supplementation can reduce the absorption of certain medications including tetracycline and fluoroquinolone antibiotics, bisphosphonates (e.g., alendronate), levothyroxine, and iron supplements, requiring a 2-hour dosing separation. Individuals with hypercalcemia, hyperparathyroidism, or calcium oxalate kidney stones should avoid high-dose calcium supplementation including Aquamin without physician supervision. Pregnancy safety has not been specifically studied for Aquamin; while dietary calcium needs increase during pregnancy, supplemental use should be discussed with a healthcare provider to avoid exceeding the tolerable upper intake level of 2,500 mg calcium/day.